BRCA1 and cancer: DNA polymerase θ (Polθ) is a polymerase-helicasefusionprotein that is synthetically lethal with homologous recombination(HR) factors, such as BRCA1/2, and confers resistance to PARP inhibitors(PARPi) and other genotoxic cancer therapies.